Shanghai Shenqi Pharmaceutical Investment Management Co. Owners

Health Care & Life Sciences » Pharmaceuticals | Shanghai Shenqi Pharmaceutical Investment Management Co. Ltd.

Shanghai Shenqi Pharmaceutical Investment Management Co. Ltd. | Ownership

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

The Vanguard Group, Inc.

424,381

0.09%

07/31/2018

GF Fund Management Co., Ltd.

116,400

0.02%

11,800

12/31/2017

Golden Eagle Asset Management Co., Ltd.

24,000

0.01%

24,000

12/31/2017

China Southern Asset Management Co., Ltd.

17,400

-169,200

12/31/2017

CICC Fund Management Ltd.

4,200

12/31/2017

China Post & Capital Fund Management Co., Ltd.

3,000

-2,500

12/31/2017

Maxwealth Fund Management Co., Ltd.

2,100

0.01%

12/31/2017

View Profile

Address	Room 613, Changfa Building Shanghai Shanghai 200003 China
Employees	-
Website	http://www.gzsq.com
Updated	07/08/2019
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. engages in the research and development, manufacture, and sale of antitumor, cardiovascular, cold and cough, children medicine, and anti fungi drugs. Its products include yening syrup, lipid detoxification, cardiovascular, high blood, and other medicines. The company was founded in 1947 and is headquartered in Shanghai, China.